Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Starting soon Not applicable

Effects of Exercise Intervention on Sleep Quality and Emotional Problems in College Students With Depressive Symptoms

NCT07738809 · tracked via the Priya Life Science China tracker
Phase
Not applicable
Started
2026-08-01
Last updated
2026-07-31

Condition(s) studied

Depressive SymptomsSleep Disturbance

Investigational drug(s) / intervention(s)

Archery ExerciseNon-exercise Control

Archery Exercise: Participants perform a standardized archery exercise program consisting of an acute exercise session followed by an 8-week supervised training program. The acute session includes a 5-minute warm-up, 20 minutes of archery exercise, and a 5-minute cool-down. The long-term intervention is conducted three times per week for 8 weeks at moderate exercise intensity.

Non-exercise Control: Participants continue their usual daily activities without participating in the archery exercise intervention.

Study summary

This exploratory randomized controlled trial aims to investigate the immediate and long-term effects of exercise on sleep quality, emotional problems, executive function, and neurophysiological characteristics in college students with depressive symptoms. The study consists of two sequential phases: an acute exercise experiment followed by an 8-week exercise intervention. Participants will be randomly assigned to either an exercise intervention group or a control group. Psychological questionnaires, behavioral tasks, resting-state electroencephalography (EEG), brain functional connectivity, and event-related potentials (ERP) will be assessed to evaluate behavioral and neurophysiological changes before and after exercise. The study will further examine whether the immediate response to acute exercise predicts the effectiveness of the long-term intervention.

Eligibility

Sex
ALL
Min age
18 Years
Max age
23 Years
Healthy volunteers
Accepted
Inclusion Criteria: * • Aged 18-23 years. * Right-handed. * Non-physical education major. * No history of psychiatric disorders and no current or previous use of psychotropic medications, hypnotics, or other medications affecting the central nervous system. * No history of traumatic brain injury or chronic physical diseases. * No contraindications to physical exercise. * Participants with a Beck Depression Inventory-II (BDI-II) score \>13 will be classified as having depressive symptoms, whereas participants with a BDI-II score ≤13 will be classified as having no depressive symptoms. Exclusion Criteria: * Vigorous physical exercise, alcohol consumption, caffeine intake, or other stimulating behaviors within 24 hours before testing. * Withdrawal from the study before completion of EEG recording or behavioral task assessments. * Participants will be excluded from the final analysis if they fail to complete the required questionnaires or if the collected data do not meet predefined quality control criteria.

Primary outcome measure(s)

  • Depressive symptoms measured by the Beck Depression Inventory-II (BDI-II) — Baseline, immediately after the acute exercise session, and after completion of the 8-week intervention.
    Depressive symptoms will be assessed using the Beck Depression Inventory-II (BDI-II). Changes in depressive symptom severity following acute and long-term archery exercise interventions will be evaluated.
  • Sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI) — Baseline, immediately after the acute exercise session, and after completion of the 8-week intervention.
    Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). Changes in sleep quality after acute and long-term archery exercise interventions will be evaluated.
  • Resting-state EEG functional connectivity — Baseline, immediately after the acute exercise session, and after completion of the 8-week intervention.
    Resting-state EEG functional connectivity will be analyzed using phase synchronization metrics to evaluate neural changes associated with archery exercise interventions.

Trial sites (1)

FacilityCityRegionStatus
Shanghai University of Sport Shanghai Shanghai Municipality
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07738809 on ClinicalTrials.gov ↗ ← All trials in China